Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results
Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
The facility is expected to become operational by FY2028-29
Nadda underlined that India’s policy framework is aligned with this transformation
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
This partnership represents a systemic shift from awareness to large-scale action for 57 lakh children
The funding comes under the AHG Catalysing Innovation Awards, part of the Addiction Healthcare Goals programme led by the Office for Life Sciences
The order will cover the manufacturing of bulk vaccine in 2026
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
Subscribe To Our Newsletter & Stay Updated
